Stockreport

What Catalysts Are Changing the Narrative for DarioHealth? [Yahoo! Finance]

DarioHealth Corp.  (DRIO) 
NASDAQ:AMEX Investor Relations: dariohealth.com/our-story
PDF DarioHealth recently saw its consensus analyst price target lowered from $19.75 to $18.25. This adjustment reflects a cautious reassessment of the company's growth traje [Read more]